European Society for Medical Oncology News More: FDA approves ribociclib-letrozole co-pack for initial treatment of HR-positive/her2-negative advanced or metastatic breast cancer Source: MDlinx
read moreAmerican Pharmacists Association News More: FDA approves combining Mercks pembrolizumab with chemotherapy in lung cancer patients Source: MDlinx
read moreRoche More: FDA approves Roches Actemra/RoActemra (tocilizumab) for giant cell arteritis Source: MDlinx
read moreEuropean Society for Medical Oncology News More: FDA approves pembrolizumab as first-line combination therapy with pemetrexed and carboplatin for metastatic non-squamous NSCLC irrespective of PD-l1 expression Source: MDlinx
read moreTalk about going on a roll. Merck’s Keytruda nabbed its third FDA approval in two weeks on Tuesday, becoming the first checkpoint inhibitor to pick up an approval to treat microsatellite instability-high cancer, a rare tumor type identified with genetic
read moreSet against the backdrop of a constantly changing and highly regulated environment, the PharmaTimes Marketer of the Year Awards will return to London on the 9th November 2017 to reward the best marketing talent in pharma. More: The PharmaTimes Marketer
read more© 1994 - 2026 B.M. Pharmaceuticals